Japanese supplier Kaneka has secured an extension for the Novel Food status of its liquorice extract Glavonoid, which is now approved for use in medical foods and energy-restricted diets.
Co-enzyme Q10 suppliers ZMC-USA and Zhejiang Medicine Company, Ltd. have filed an amended complaint against Kaneka Corporation for damages in excess of $100 million in an ongoing dispute over CoQ10 patents.
One of the bastions of the CoQ10 market in Japan, Kaneka Nutrients,
is bringing its ingredient to the US food and beverage
industries through PL Thomas.
The huge demand for coenzyme Q10, inflating prices to record highs,
is boosting the market for fraudulent products, and threatening
leading manufacturer Kaneka's brand, reports Dominique
Patton.